covid19-public
covid19-public copied to clipboard
MoH-Malaysia
Availability of reinfection cases for the unvaccinated
As of now, it is either zero or N/A. I don't believe it's the former. For completeness (so we may have finer granularity by breaking down immunity category into vaccine-immunity, natural-immunity and hybrid-immunity), kindly provide the necessary information. This will help shaping current SOPs as well as to give guidance for future vaccination programme.
Thank you.
Discrepancies; we need our own data to make better sense of things: https://youtu.be/6Gn5GtUpwQ0?t=272
Based on this scientific study, the reinfection cases only occurred around 0.33% which translated to a very low incidence. https://academic.oup.com/jpubhealth/advance-article/doi/10.1093/pubmed/fdab346/6366077?login=true&fbclid=IwAR13b6rI_ufplHQyKmCdwQthKoedN8zAVQjqrgRPQJv4uyxkw_r47v50l8s
This is also supported by another study that had found natural immunity 13x stronger, robust and long-lasting compared to acquired immunity through a vaccine. This is the reason why reinfection cases rarely happened. https://www.medrxiv.org/content/10.1101/2021.08.24.21262415v1.full-text
This is not good: https://youtu.be/-Ia5l0p4gI4?t=150 . Does it transpire here as well? Hence no response until now?
2 (no difference between immunities) vs. 1 (noticeable difference): https://youtu.be/E89taTH86_s?t=440
Undiscernable relationship (ourworldindata.org): https://youtu.be/HeSJWGSnN8A?t=945
Study on vitamin D3 vs. Covid-19 mortality rate: https://youtu.be/fbGug3rczx4?t=125
Simple enough for us to replicate using our own data, yet overwhelmingly impactful on shaping our future outlook towards Covid-19 endemicity.
Sorry for the late reply. I'm quite busy with my works. Not have enough time to concentrate on this issue until all my works are done.
On Fri, Nov 19, 2021 at 7:08 AM jstumpin @.***> wrote:
Study on vitamin D3 vs. Covid-19 mortality rate: https://youtu.be/fbGug3rczx4?t=125
Simple enough for us to replicate using our own data, yet overwhelmingly impactful for our future outlook on Covid-19 prevention.
— You are receiving this because you commented. Reply to this email directly, view it on GitHub https://github.com/MoH-Malaysia/covid19-public/issues/201#issuecomment-973387957, or unsubscribe https://github.com/notifications/unsubscribe-auth/AV67XIVZYMUGGW5CPQZUKU3UMWBOVANCNFSM5FJQIX5Q . Triage notifications on the go with GitHub Mobile for iOS https://apps.apple.com/app/apple-store/id1477376905?ct=notification-email&mt=8&pt=524675 or Android https://play.google.com/store/apps/details?id=com.github.android&referrer=utm_campaign%3Dnotification-email%26utm_medium%3Demail%26utm_source%3Dgithub.
Pfizer(82%) < Natural-Immunity(73%) < AstraZeneca(67%): https://youtu.be/64OTXmp3YRI
Full excerpt from the paper reviewed in the video:
However a recent pre-print from a study conducted in the United Kingdom found among persons infected during a period of nearly exclusive Delta SARS-CoV-2 transmission, those fully vaccinated with BNT162b2@Pfizer and ChAd0x1@AstraZeneca (had similar levels of protection (82% and 67%, respectively) as those with previous infection (73%) (Pouwels et al., 2021). https://journals.sagepub.com/doi/full/10.1177/01632787211047932